Sat, Apr 19, 2014, 1:49 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Metabolix, Inc. Message Board

  • ready788 ready788 Feb 5, 2013 2:14 PM Flag

    When do we find out who added 1 million shares in Dec?

    If it was an instittution, doesn'[t that need to be public soon? Was it a 1st step towards a hostile take over? may have to add if it gets to wchuck price.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Firms have until Feb 14th 2013 to report positions for 12/31/2012.. some have already reported

      7/9 reporting have been sellers including Vanguard which sold over 1mm and 3 others that sold out

      1 Aperio purchased 36k and now holds 121K

    • beprepared4infinityandbeyond beprepared4infinityandbeyond Feb 5, 2013 2:25 PM Flag

      "Mr. Jack W. Schuler Co-founded Crabtree Partners LLC in June 1995 and serves as its Partner. Mr. Schuler served as the President and Chief Operating Officer of Abbott Laboratories, health care products, from January 1987 to August 1989 and served as its Executive Vice President from 1985 to 1987. Prior to 1990, Mr. Schuler held various executive positions at Abbott Laboratories, a broad-based healthcare company from December 1972 to August 1989. He has over 30 years of experience in the pharmaceutical industry. Prior to his career at Abbott, he was employed by Texas Instruments and served Texas Instruments for eight years in France, Germany and Japan. Mr. Schuler has been the Chairman of the Board of Ventana Medical Systems Inc. since November 1995. He served as the Chairman of 3CI Complete Compliance Corp. since October 1998 and Stericycle Inc. from January 1990 to August 2008. Mr. Schuler has been a Director of Stericycle Inc. since January 1990 and its Lead Director since August 2008. He has been an Independent Director of Quidel Corp. since February 7, 2006 and Ventana Medical Systems Inc. since April 1991. Mr. Schuler has been a Director of Medtronic Minimed, Inc. and Medtronic Inc. since 1990. He has been a Director of Biodesix, Inc., since June 2008. He serves as a Member of Scientific Advisory Board at Epitomics, Inc. He has been a Director of ICOS Corporation since January 2004. He serves as a Director at Accelr8 Technology Corp. since June 26, 2012. He serves as a Director of Takeda Pharmaceuticals North America Inc. He serves as a Trustee of Carleton College. Mr. Schuler served as a Lead Director of Medtronic, Inc. He served as a Member of the Board Of Directors of Chiron Corporation from 1990 to 2003, Abbott Laboratories from April 1985 to August 1989 and 3CI Complete Compliance Corp. from October 1998 to April 2004. He served as a Director of Elan Corp. plc. since July 16, 2009 and Baxter Hemoglobin Therapeutics, Inc., (formerly, Somatogen, Inc.) since June 1991. Mr. Schuler received a B.S. in Pharmacy from University of North Carolina. Mr. Schuler received a B.S. in Mechanical Engineering from Tufts University and an M.B.A. from Stanford University Graduate School of Business Administration." - Bio from Bloomberg

      Jack owns nearly 15% of this company and many of his shares were purchased above $6 with him nearly doubling down in January of last year when it dropped near $2.50

      You can bet that if you want to take over the company you'll have to go through Jack and it will cost you several multiples of today's price :)

      Don't worry, there is a turnaround going on here and the company currently has the cash to do it right.

      Sentiment: Strong Buy

 
MBLX
0.9402-0.0098(-1.03%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT